1 |
Klijn A, Mercenier A, Arigoni F. 2005. Lessons from the genomes of bifidobacteria. FEMS Microbiol Rev 29: 491-509
DOI
ScienceOn
|
2 |
Yan F, Polk DB. 2006. Probiotics as functional food in the treatment of diarrhea. Curr Opin Clin Nutr Metab Care 9: 717-721
DOI
ScienceOn
|
3 |
Ventura M, O'Connell-Motherway M, Leahy S, Moreno-Munoz JA, Fitzgerald GF, van Sinderen D. 2007. From bacterial genome to functionality; case bifidobacteria. Int J Food Microbiol 120: 2-12
DOI
ScienceOn
|
4 |
Sanchez B, Champomier-Verges MC, Anglade P, Baraige F, de los Reyes-Gavilan CG, Margolles A, Zagorec M. 2008. A preliminary analysis of Bifidobacterium longum exported proteins by two-dimensional electrophoresis. J Mol Microbiol Biotechnol 14: 74-79
DOI
ScienceOn
|
5 |
De Dea Lindner J, Canchaya C, Zhang Ziding, Neviani E, Fitzgerald GF, van Sinderen D, Ventura M. 2007. Exploiting Bifidobacterium genomes: The molecular basis of stress response. Int J Food Microbiol 120: 13-24
DOI
ScienceOn
|
6 |
Crosa JH. 1997. Signal transduction and transcriptional and posttranscriptional control of iron-regulated genes in bacteria. Microbiol Mol Biol Rev 61: 319-336
|
7 |
O'Sullivan DJ. 2004. Isolated bifidobacteria that produce siderophores which inhibit growth of Lactococcus lactis. US Patent 6746672
|
8 |
Schell MA, Karmirantzou M, Snel B, Vilanova D, Berger B, Pessi G, Zwahlen MC, Desiere F, Bork P, Delley M, Pridmore RD, Arigoni F. 2002. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci USA 99: 14422-14427
DOI
ScienceOn
|
9 |
MacConaill LE, Fitzgerald GF, van Sinderen D. 2003. Investigation of protein export in Bifidobacterium breve UCC2003. Appl Environ Microbiol 69: 6994-7001
DOI
|
10 |
Persson B, Kallberg Y, Oppermann U, Jornvall H. 2003. Coenzyme-based functional assignments of short-chain dehydrogenase/reductase (SDRs). Chem Biol Interact 143-144: 271-278
DOI
ScienceOn
|
11 |
Sanz Y, Nadal I, Sanchez E. 2007. Probiotics as drugs against human gastrointestinal infections. Recent Patents Anti-Infect Drug Disc 2: 148-156
DOI
|
12 |
Gueimonde M, Margolles A, de los Reyes-Gavilan CG, Salminen S. 2007. Competitive exclusion of enteropathogens from human intestinal mucus by Bifidobacterium strains with acquired resistance to bile–A preliminary study. Int J Food Microbiol 113: 228-232
DOI
ScienceOn
|
13 |
Amenta M, Cascio MT, Di Fiore P, Venturini I. 2006. Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 FOS Actilight). Acta Biomed 77: 157-162
|
14 |
Medina M, Izquierdo E, Ennahar S, Sanz Y. 2007. Differential immunomodulatory properties of Bifidobacterium longum strains: relevance to probiotic selection and clinical applications. Clin Exp Immunol 150: 531-538
DOI
ScienceOn
|
15 |
Dale SE, Sebulsky MT, Heinrichs DE. 2004. Involvement of SirABC in iron-siderophore import in Staphylococcus aureus. J Bacteriol 186: 8356-8362
DOI
ScienceOn
|
16 |
Boirivant M, Strober W. 2007. The mechanism of action of probiotics. Curr Opin Gastroenterol 23: 679-692
DOI
ScienceOn
|